Skip to content

ANTIPODES PARTNERS Ltd: AEP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on AEP, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,699,356 AEP shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,699,356 shares
    Change vs previous 13F -110,730 shares

    4.26% of the 13F portfolio, value $232,488,894.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,810,086 shares
    Change vs previous 13F -18,884 shares

    4.57% of the 13F portfolio, value $237,266,073.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,828,970 shares
    Change vs previous 13F -347,118 shares

    4.43% of the 13F portfolio, value $210,914,344.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,176,088 shares
    Change vs previous 13F +1,044,629 shares

    5.49% of the 13F portfolio, value $244,828,369.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,131,459 shares
    Change vs previous 13F -161,785 shares

    3.64% of the 13F portfolio, value $117,409,143.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,293,244 shares
    Change vs previous 13F -93,131 shares

    4.43% of the 13F portfolio, value $141,324,110.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,386,375 shares
    Change vs previous 13F +673,644 shares

    4.44% of the 13F portfolio, value $127,875,692.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 712,731 shares
    Change vs previous 13F not available

    2.53% of the 13F portfolio, value $73,131,471.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).